Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Shilpa Medicare zooms 5% after USFDA concludes inspection of Telangana facility

The stock witnessed spurt in volume by more than 1.17 times. It was trading with volumes of 3,249 shares, compared to its five-day average of 1,886 shares, an increase of 72.27 percent.

September 09, 2019 / 11:52 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shilpa Medicare zoomed over 5 percent intraday on September 9 after US Food and Drug Administration (USFDA) concluded inspection of its facility.

USFDA inspected Shilpa Medicare’s Finished Dosage Formulation Facility (Sterile and Non-sterile Dosage Forms) in Telangana's Jadcherla town from August 29 to September 6.

The stock witnessed spurt in volume by more than 1.17 times. It was trading with volumes of 3,249 shares, compared to its five-day average of 1,886 shares, an increase of 72.27 percent.

At 1136 hours, Shilpa Medicare was quoting at Rs 274.00, up Rs 14.35, or 5.53 percent. It touched an intraday high of Rs 275.00 and an intraday low of Rs 260.50.

Moneycontrol News
first published: Sep 9, 2019 11:52 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347